Evotec SE (NASDAQ:EVO) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to the Evotec SE Quarterly Statement Q1 2024 Conference Call. I am Sandra, the chorus call operator.
Stay updated with breaking news from Matthias Evers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Ladies and gentlemen, welcome to the Evotec SE Quarterly Statement Q1 2024 Conference Call. I am Sandra, the chorus call operator.
Evotec SE misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were $-0.03333.
EQS-News: Evotec SE / Key word: Miscellaneous Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments 18.04.2024 / 13:27...
Just - Evotec Biologics Expands Development and Manufacturing Agreement ...
EQS-News: Evotec SE / Key word: Miscellaneous Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV...